ArticleClinical pharmacology and therapeutics2025
Confirmation of Fixed Quarterly Riliprubart Regimen in Patients with Cold Agglutinin Disease Using Population PK/PD and Exposure-Response Analyses.
Timothy Chow et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.